Encompass Health Co. (NYSE:EHC) Receives $107.11 Average Target Price from Analysts

Shares of Encompass Health Co. (NYSE:EHC) have received an average recommendation of “Buy” from the eleven analysts that are presently covering the stock, MarketBeat Ratings reports. Nine analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. The average twelve-month price objective among brokers that have issued a report on the stock in the last year is $107.11.

Several analysts recently issued reports on EHC shares. Royal Bank of Canada increased their price objective on Encompass Health from $105.00 to $110.00 and gave the stock an “outperform” rating in a report on Wednesday, October 30th. KeyCorp raised their price objective on shares of Encompass Health from $115.00 to $117.00 and gave the company an “overweight” rating in a research report on Tuesday, October 29th. Barclays increased their price target on shares of Encompass Health from $109.00 to $116.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 29th. Truist Financial reaffirmed a “buy” rating and issued a $116.00 price objective (up previously from $108.00) on shares of Encompass Health in a research note on Wednesday, October 30th. Finally, UBS Group raised their target price on Encompass Health from $100.00 to $110.00 and gave the company a “buy” rating in a report on Wednesday, September 25th.

Encompass Health Price Performance

EHC stock opened at $91.85 on Tuesday. The firm has a 50-day moving average of $99.00 and a two-hundred day moving average of $93.39. The firm has a market capitalization of $9.25 billion, a PE ratio of 22.19, a P/E/G ratio of 1.30 and a beta of 0.86. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.88. Encompass Health has a one year low of $66.36 and a one year high of $104.55.

Encompass Health (NYSE:EHC) last announced its quarterly earnings data on Monday, October 28th. The company reported $1.03 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.94 by $0.09. The firm had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.33 billion. Encompass Health had a return on equity of 17.60% and a net margin of 8.10%. The business’s revenue for the quarter was up 11.9% on a year-over-year basis. During the same period in the prior year, the business earned $0.86 EPS. On average, analysts forecast that Encompass Health will post 4.29 earnings per share for the current year.

Encompass Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 15th. Stockholders of record on Thursday, January 2nd will be issued a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a dividend yield of 0.74%. The ex-dividend date is Thursday, January 2nd. Encompass Health’s dividend payout ratio (DPR) is presently 16.43%.

Institutional Trading of Encompass Health

Hedge funds and other institutional investors have recently made changes to their positions in the business. Franklin Resources Inc. lifted its holdings in Encompass Health by 22.0% during the 3rd quarter. Franklin Resources Inc. now owns 700,021 shares of the company’s stock valued at $67,412,000 after purchasing an additional 126,000 shares during the last quarter. Synovus Financial Corp raised its position in shares of Encompass Health by 92.9% in the third quarter. Synovus Financial Corp now owns 16,057 shares of the company’s stock valued at $1,552,000 after buying an additional 7,733 shares in the last quarter. Tidal Investments LLC boosted its stake in shares of Encompass Health by 5.7% in the third quarter. Tidal Investments LLC now owns 3,509 shares of the company’s stock valued at $339,000 after buying an additional 188 shares during the period. TD Private Client Wealth LLC increased its stake in Encompass Health by 2,870.0% during the 3rd quarter. TD Private Client Wealth LLC now owns 7,336 shares of the company’s stock worth $709,000 after acquiring an additional 7,089 shares during the period. Finally, Coldstream Capital Management Inc. raised its holdings in Encompass Health by 4.1% in the 3rd quarter. Coldstream Capital Management Inc. now owns 27,636 shares of the company’s stock valued at $2,672,000 after acquiring an additional 1,088 shares in the last quarter. 97.25% of the stock is currently owned by institutional investors and hedge funds.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.